Furthermore, a new steroid compound (steroid-based copper transporter 1 inhibitors) has also been discovered, which can suppress PCa cell proliferation and tumor growth by reducing copper uptake and may act as a novel anti-cancer drug for PCa [64]. Here, SLC31A1 is linked to posterior cortical atrophy.